BMA
PFE icon

Brooks Moore & Associates’s Pfizer PFE Stock Holding History

Brooks Moore & Associates’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-18,366
Closed -$609K – 87
2023
Q3 		$609K Sell
18,366
-600
-3% -$21.2K 0.46% 53
2023
Q2 		$696K Sell
18,966
-300
-2% -$11.7K 0.49% 52
2023
Q1 		$786K Buy
19,266
+3,600
+23% +$155K 0.56% 50
2022
Q4 		$803K Buy
15,666
+862
+6% +$41.3K 0.59% 45
2022
Q3 		$648K Sell
14,804
-75
-0.5% -$3.64K 0.52% 45
2022
Q2 		$780K Hold
14,879
– – 0.56% 47
2022
Q1 		$770K Sell
14,879
-1,398
-9% -$72.5K 0.47% 57
2021
Q4 		$961K Sell
16,277
-201
-1% -$9.96K 0.56% 46
2021
Q3 		$709K Sell
16,478
-187
-1% -$8.28K 0.46% 58
2021
Q2 		$653K Buy
16,665
+513
+3% +$19.9K 0.42% 62
2021
Q1 		$585K Buy
16,152
+2,314
+17% +$82.2K 0.4% 62
2020
Q4 		$509K Sell
13,838
-958
-6% -$35.1K 0.39% 64
2020
Q3 		$515K Buy
14,796
+1,366
+10% +$47.9K 0.44% 60
2020
Q2 		$417K Sell
13,430
-11,841
-47% -$402K 0.39% 62
2020
Q1 		$783K Sell
25,271
-158
-0.6% -$5.38K 0.83% 41
2019
Q4 		$945K Sell
25,429
-2,354
-8% -$83.8K 0.75% 47
2019
Q3 		$947K Sell
27,783
-503
-2% -$18.3K 0.8% 44
2019
Q2 		$1.16M Buy
28,286
+1,526
+6% +$60.6K 1% 37
2019
Q1 		$1.08M Buy
26,760
+530
+2% +$21.2K 0.98% 38
2018
Q4 		$1.09M Buy
+26,230
New +$1.09M 1.09% 35

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Brooks Moore & Associates's PFE Position: Q4 2023 in Review

Brooks Moore & Associates sold out of Pfizer (PFE) in Q4 2023, closing a stake of 18,366 shares — an estimated $609K sold.

Brooks Moore & Associates first reported a position in PFE in Q4 2018 and held it in 20 quarters. The position peaked at $1.16M in Q2 2019. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • Brooks Moore & Associates reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
  • Brooks Moore & Associates sold 18,366 Pfizer shares in Q4 2023, an estimated $609K.
  • Brooks Moore & Associates first reported a position in Pfizer in Q4 2018 and held it in 20 quarters.
  • Brooks Moore & Associates's Pfizer position peaked at $1.16M in Q2 2019.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Brooks Moore & Associates's 13F filing for Q4 2023, filed 15 Feb 2024.